Versant Venture Capital Vi, L.P. Aligos Therapeutics, Inc. (ALGS) insider trading activity

ALGS Quotes by TradingView

Versant Venture Capital VI, L.P. Transaction History

Date Transaction Value Shares Traded Form
Oct 20 2020
BUY
Conversion of derivative security
-
662,444
Oct 20 2020
BUY
Open market or private purchase
$3,000,000 $15.0 p/Share
200,000

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
> 10% Shareholder
IPSC
Century Therapeutics, Inc. Healthcare
> 10% Shareholder
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
GRPH
Graphite Bio, Inc. Healthcare
CTNM
Contineum Therapeutics, Inc.
> 10% Shareholder
TPST
Tempest Therapeutics, Inc. Healthcare
VVC

Versant Venture Capital Vi, L.P.

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on ALGS

Follow Aligos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALGS shares.

Notify only if

Insider Trading

Get notified when an Aligos Therapeutics, Inc. insider buys or sells ALGS shares.

Notify only if

News

Receive news related to Aligos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALGS